跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 154 条关于
“Jebbound”
全部
154
临床试验
110
药物
0
机构
0
资讯
44
去年
Obesity Drug Concerns: Muscle Loss and Weight Regain Highlighted by Regeneron CEO
去年
D&D Pharmatech's DD01 Shows Rapid Liver Fat Reduction in MASH Phase 2 Trial, Matching Competitor Results in Quarter of the Time
去年
FDA Approves Zepbound (tirzepatide) for Obstructive Sleep Apnea
2年前
FDA Approves Zepbound (Tirzepatide) for Weight Loss
去年
Tirzepatide (Zepbound) Shows Promise in Reducing Heart Failure Deaths in Obese Patients
去年
Eli Lilly's Zepbound Demonstrates Superior Weight Loss Compared to Novo Nordisk's Wegovy in Head-to-Head Trial
去年
Eli Lilly Expands Zepbound Access Through Noom and Teladoc Partnerships
2年前
Zepbound Shows Greater Weight Loss Efficacy in Women, Study Finds
去年
Eli Lilly's Zepbound Anticipates Approval in Japan by Mid-2025
9个月前
Zepbound Weight-Loss Drug Enters Clinical Testing for Long Covid Treatment
第 1 页,共 5 页
上一页
下一页